www.jpmorganmarkets.comNorthAmericaEquityResearch01July2019LifeInsurance2Q19OutlookDropinRatesandStrongYTDPerformanceMakeLifeStocksLessCompellingInsurance--LifeJimmyS.Bhullar,CFAAC(1-212)622-6397jimmy.s.bhullar@jpmorgan.comBloombergJPMABHULLARPabloS.Singzon(1-212)622-2295pablo.s.singzon@jpmorgan.comJ.P.MorganSecuritiesLLCSeepage111foranalystcertificationandimportantdisclosures.J.P.Morgandoesandseekstodobusinesswithcompaniescoveredinitsresearchreports.Asaresult,investorsshouldbeawarethatthefirmmayhaveaconflictofinterestthatcouldaffecttheobjectivityofthisreport.Investorsshouldconsiderthisreportasonlyasinglefactorinmakingtheirinvestmentdecision.Weareshiftingourviewonthelifeinsurancesectorfrompositivetoneutral.Ouroutlookforbusinessfundamentalsisconsistentwithpreviously,butwefeelthatthesharpdropininterestratesandthegroup’sstrongperformancemakestherisk-rewardinstockslesscompelling.Wefeelthatlifestockshavenotfullyadjustedtoreflectthedeclineinrates.This,alongwithexpectedreductionsinEPSforecastscouldweighonthegroup’sperformance.ReducingEPSestimates.Wearecuttingestimatesformostlifeinsurerstoreflectthedeclineinnewmoneyyieldsandothercompany-specificfactors,partlyoffsetbythestrongequitymarketin2Q19.Ourforecastsformostinsurersarebelowconsensus,butwefeelthat2QestimatesforAIG,HIG,andMETareespeciallyoptimistic.For2020,weareconsiderablybelowconsensusonAIG,ATH,andVOYA,butslightlyaboveforAFLandPFG.Weexpectlifeinsurerstoreporthealthyresultsin2Q19.AlthoughourEPSestimatesarebelowconsensus,weexpectbusinesstrendstobehealthyoverall,markedbyrobustalternativeinvestmentincome(giventhe1-quarterlagforprivateequityfunds),asequentialincreaseinfeeincome(duetothestrongequitymarket),andstablemortality/morbiditymargins.Onacautiousnote,weexpectorganicgrowthformostlifeinsuranceproductstobepoor.Ourlong-termoutlookisdownbeat.Onapositivenote,lifeinsurershaveamplecapitalflexibilityforongoingsharebuybacksanddividendhikes.Inaddition,weexpectpricecompetitioninmostproductstoberational.Conversely,w...